enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Biotech company Regeneron buys Avon site in Rockland ... - AOL

   www.aol.com/biotech-company-regeneron-buys-avon...

   Massive Regeneron expansion: Company plan could make Westchester a capital of biotech industry Regeneron reports it has more than 12,000 employees and offices in seven countries.

3. Regeneron Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Regeneron_Pharmaceuticals

   Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a ...

4. Regeneron Named to Dow Jones Sustainability World Index for ...

   lite.aol.com/tech/story/0022/20241216/9319964.htm

   Regeneron is proud to be included in the Dow Jones Sustainability World Index and the Civic 50 list of the most “community-minded” companies in the U.S. Throughout the year, Regeneron empowers and supports employees to give back through our volunteering, pro bono and matching gift programs.

5. List of largest biomedical companies by revenue - Wikipedia

   en.wikipedia.org/wiki/List_of_largest_biomedical...

   The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.

6. Regeneron to collaborate on gene editing therapies with ...

   www.aol.com/news/regeneron-collaborate-gene...

   Mammoth's CRISPR-based gene editing platform and Regeneron's delivery technologies will be used to create disease-modifying medicines that can be delivered to tissues beyond the liver. CRISPR ...

7. Regeneron's Eylea could return to growth after nod to high ...

   www.aol.com/news/regenerons-eylea-could-return...

   Shares of Regeneron rose 1.7% to $826.4 in early trading. A longer dosing gap for the drug could help Regeneron take on rival Roche's Vabysmo and also help soften the blow from incoming cheaper ...

8. George Yancopoulos - Wikipedia

   en.wikipedia.org/wiki/George_Yancopoulos

   In 2014, Yancopoulos led the launch of the Regeneron Genetics Center, a major initiative in human genetic research that has sequenced exomes from over 1,000,000 people as of February 2020. [23] [24] Forbes magazine states Yancopoulos' financial stake in Regeneron has made him a billionaire. He is the first research and development chief in the ...

9. Regeneron beats quarterly results on strong demand for ... - AOL

   www.aol.com/news/regeneron-beats-quarterly...

   Regeneron reported an adjusted profit of $11.56 per share on total revenue of $3.55 billion for the quarter, above analysts' estimates of $10.61 per share and $3.38 billion, according to LSEG data.